Ablative and catheter-delivered therapies for colorectal liver metastases (CRLM)

European Journal of Surgical Oncology

Volumn 33, Issue SUPPL. 2, 2007, Pages

  Evans, J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Ablation; Colorectal liver metastases; Embolisation; Percutaneous; Review; Trans arterial; Treatment

Indexed keywords

ALCOHOL; CISPLATIN; DOXORUBICIN; EPIRUBICIN; INTERFERON; IRINOTECAN; MITOMYCIN;

ARTIFICIAL EMBOLISM; CANCER RADIOTHERAPY; CATHETER ABLATION; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; ECHOGRAPHY; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; LIVER METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; THERAPY EFFECT;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CATHETER ABLATION; COLORECTAL NEOPLASMS; CRYOTHERAPY; EMBOLIZATION, THERAPEUTIC; ETHANOL; HUMANS; INJECTIONS, INTRALESIONAL; LASER THERAPY; LIVER NEOPLASMS; MICROWAVES;

EID: 36749045327     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.027     Document Type: Review

References (110)

1. Population screening for colorectal cancer. Drug Ther Bull 44 9 (2006) 65-68
2. McLoughlin J.M., Jensen E.H., and Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control 13 1 (2006) 32-41
3. Wei A.C., Greig P.D., Grant D., Taylor B., Langer B., and Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13 5 (2006) 668-676
4. Cummings L.C., Payes J.D., and Cooper G.S. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109 4 (2007) 718-726
5. Kornprat P., Jarnagin W.R., Gonen M., et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14 3 (2007) 1151-1160
6. Hamady Z.Z., Malik H.Z., Finch R., et al. Hepatic resection for colorectal metastasis: impact of tumour size. Ann Surg Oncol 13 11 (2006) 1493-1499
7. Pawlik T.M., Abdalla E.K., Ellis L.M., Vauthey J.N., and Curley S.A. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 10 2 (2006) 240-248
8. Ercolani G., Grazi G.L., Ravaioli M., et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 137 10 (2002) 1187-1192
9. Trerotola S.O. Science to practice: can combination therapy for colorectal liver metastases improve results over chemoembolization or ablation alone?. Radiology 237 2 (2005) 381-382
10. Figueras J., Burdio F., Ramos E., et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol (2007)
11. Wray C.J., Lowy A.M., Mathews J.B., et al. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol 12 5 (2005) 374-380
12. Hamady Z.Z., Cameron I.C., Wyatt J., Prasad R.K., Toogood G.J., and Lodge J.P. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol 32 5 (2006) 557-563
13. Pawlik T.M., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 5 (2005) 715-722 [discussion 722-724]
14. Jain S., Sacchi M., Vrachnos P., Lygidakis N.J., and Andriopoulou E. Recent advances in the treatment of colorectal liver metastases. Hepatogastroenterology 52 65 (2005) 1567-1584
15. Vogl T.J., Straub R., Zangos S., Mack M.G., and Eichler K. MR-guided laser-induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperthermia 20 7 (2004) 713-724
16. Yarmenitis S.D., Karantanas A., Bakantaki A., Papantoniou Y., and Gourtsoyiannis N. Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: comparison with conventional B-mode ultrasound. Dig Dis 25 1 (2007) 86-93
17. Jung E.M., Clevert D.A., and Rupp N. Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors. Rofo 175 10 (2003) 1403-1412
18. Solbiati L., Goldberg S.N., Ierace T., Dellanoce M., Livraghi T., and Gazelle G.S. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 211 3 (1999) 643-649
19. Cioni D., Lencioni R., and Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 13 2 (2001) 73-93
20. Silverman P.M. Liver metastases: imaging considerations for protocol development with multislice CT (MSCT). Cancer Imaging 6 (2006) 175-181
21. Das M., Sauer F., Schoepf U.J., et al. Augmented reality visualization for CT-guided interventions: system description, feasibility, and initial evaluation in an abdominal phantom. Radiology 240 1 (2006) 230-235
22. Nicolau S.A., Pennec X., Soler L., and Ayache N. A complete augmented reality guidance system for liver punctures: first clinical evaluation. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 8 Pt 1 (2005) 539-547
23. Breen M.S., Lazebnik R.S., Nour S.G., Lewin J.S., and Wilson D.L. Three-dimensional comparison of interventional MR radiofrequency ablation images with tissue response. Comput Aided Surg 9 5 (2004) 185-191
24. Breen M.S., Lazebnik R.S., Fitzmaurice M., Nour S.G., Lewin J.S., and Wilson D.L. Radiofrequency thermal ablation: correlation of hyperacute MR lesion images with tissue response. J Magn Reson Imaging 20 3 (2004) 475-486
25. Samset E. Temperature mapping of thermal ablation using MRI. Minim Invasive Ther Allied Technol 15 1 (2006) 36-41
26. Samset E., Mala T., Aurdal L., and Balasingham I. Intra-operative visualisation of 3D temperature maps and 3D navigation during tissue cryoablation. Comput Med Imaging Graph 29 6 (2005) 499-505
27. Wansapura J.P., Daniel B.L., Vigen K.K., and Butts K. In vivo MR thermometry of frozen tissue using R2* and signal intensity. Acad Radiol 12 9 (2005) 1080-1084
28. Fournial R., Traoré A.S., Laurendeau D., and Moisan C. An analytic method to predict the thermal map of cryosurgery iceballs in MR images. IEEE Trans Med Imaging 23 1 (2004) 122-129
29. Ebara M., Okabe S., Kita K., et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 43 3 (2005) 458-464
30. Becker D., Hänsler J.M., Strobel D., and Hahn E.G. Percutaneous ethanol injection and radio-frequency ablation for the treatment of nonresectable colorectal liver metastases - techniques and results. Langenbecks Arch Surg 384 4 (1999) 339-343
31. Giovannini M. Percutaneous alcohol ablation for liver metastasis. Semin Oncol 29 2 (2002) 192-195
32. Giovannini M., and Seitz J.F. Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer 73 2 (1994) 294-297
33. Livraghi T., Vettori C., and Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology 179 3 (1991) 709-712
34. Puls R., Hosten N., Stroszczynski C., Kreissig R., Gaffke G., and Felix R. Laser-induced thermotherapy (LITT). Use of round and pointed laser applicator systems - initial results. Rofo 173 3 (2001) 263-265
35. Veenendaal L.M., de Jager A., Stapper G., Borel Rinkes I.H., and van Hillegersberg R. Multiple fiber laser-induced thermotherapy for ablation of large intrahepatic tumors. Photomed Laser Surg 24 1 (2006) 3-9
36. Strickland A.D., Clegg P.J., Cronin N.J., et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg 89 8 (2002) 1003-1007
37. Kuang M., Lu M.D., Xie X.Y., et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna - experimental and clinical studies. Radiology 242 3 (2007) 914-924
38. Rudmik L.R., and Magliocco A.M. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol 92 4 (2005) 347-359
39. Meyers M.O., and Watson J.C. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am 12 1 (2003) 151-163
40. Ahmad S.A., Berman R.S., and Ellis L.M. Biology of colorectal liver metastases. Surg Oncol Clin N Am 12 1 (2003) 135-150
41. Takeda A., Stoeltzing O., Ahmad S.A., et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol 9 7 (2002) 610-616
42. Horton K.M., Abrams R.A., and Fishman E.K. Spiral CT of colon cancer: imaging features and role in management. Radiographics 20 2 (2000) 419-430
43. Covey A.M., Brody L.A., Maluccio M.A., Getrajdman G.I., and Brown K.T. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224 2 (2002) 542-547
44. Chen C.Y., Lee R.C., Tseng H.S., Chiang J.H., Hwang J.I., and Teng M.M. Normal and variant anatomy of hepatic arteries: angiographic experience. Zhonghua Yi Xue Za Zhi (Taipei) 61 1 (1998) 17-23
45. Hemming A.W., Finley R.J., Evans K.G., Nelems B., and Fradet G. Esophagogastrectomy and the variant left hepatic artery. Ann Thorac Surg 54 1 (1992) 166-168
46. Chung J.W., Kim H.C., Yoon J.H., et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol 7 4 (2006) 257-266
47. Charnsangavej C., Chuang V.P., Wallace S., Soo C.S., and Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 144 3 (1982) 485-494
48. Georgiades C.S., Hong K., D'Angelo M., and Geschwind J.F. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16 12 (2005) 1653-1659
49. Zangos S., Gille T., Eichler K., et al. Transarterial chemoembolization in hepatocellular carcinomas: technique, indications, results. Radiologe 41 10 (2001) 906-914
50. Marelli L., Stigliano R., Triantos C., et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30 1 (2007) 6-25
51. Sanz-Altamira P.M., Spence L.D., Huberman M.S., et al. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 40 7 (1997) 770-775
52. Salman H.S., Cynamon J., Jagust M., et al. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2 3 (2002) 173-179
53. Lang E.K., and Brown Jr. C.L. Colorectal metastases to the liver: selective chemoembolization. Radiology 189 2 (1993) 417-422
54. You Y.T., Changchien C.R., Huang J.S., and Ng K.K. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer. Int J Colorectal Dis 21 1 (2006) 33-37
55. Ganaha F., Sadaoka S., and Yamada T. Continuous arterial infusion strategies using implanted ports. Tech Vasc Interv Radiol 5 3 (2002) 170-176
56. Grosso M., Zanon C., Zanon E., et al. The percutaneous placement of intra-arterial catheters with "reservoirs" for subcutaneous infusion. The technic and preliminary results. Radiol Med (Torino) 94 3 (1997) 226-232
57. Kuroiwa T., Honda H., Yoshimitsu K., et al. Complications encountered with a transfemorally placed port-catheter system for hepatic artery chemotherapy infusion. Cardiovasc Intervent Radiol 24 2 (2001) 90-93
58. Taylor R.R., Tang Y., Gonzalez M.V., Stratford P.W., and Lewis A.L. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30 1 (2007) 7-14
59. Russell A.H., Clyde C., Wasserman T.H., Turner S.S., and Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 27 1 (1993) 117-123
60. Welsh J.S., Kennedy A.S., and Thomadsen B. Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66 2 Suppl (2006) S62-S73
61. Nijsen J.F., van het Schip A.D., Hennink W.E., Rook D.W., van Rijk P.P., and de Klerk J.M. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem 9 1 (2002) 73-82
62. Salem R., and Thurston K.G. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17 8 (2006) 1251-1278
63. Salem R., and Thurston K.G. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 17 9 (2006) 1425-1439
64. Salem R., and Thurston K.G. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 17 10 (2006) 1571-1593
65. Murthy R., Brown D.B., Salem R., et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18 4 (2007) 553-561
66. Bianchi H.F., and Albanese E.F. The supraduodenal artery. Surg Radiol Anat 11 1 (1989) 37-40
67. Wind P., Chevallier J.M., Sarcy J.J., Delmas V., and Cugnenc P.H. The infrapyloric artery and cephalic pancreatoduodenectomy with pylorus preservation: preliminary study. Surg Radiol Anat 16 2 (1994) 165-172
68. Catalano O., Esposito M., Nunziata A., and Siani A. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging 25 6 (2000) 607-614
69. Szyszko T., Al-Nahhas A., Canelo R., et al. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography. Nucl Med Commun 28 1 (2007) 15-20
70. de Geus-Oei L.F., Ruers T.J., Punt C.J., Leer J.W., Corstens F.H., and Oyen W.J. FDG-PET in colorectal cancer. Cancer Imaging 6 (2006) S71-S81
71. Veit P., Antoch G., Stergar H., Bockisch A., Forsting M., and Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16 1 (2006) 80-87
72. Wiering B., Ruers T.J., and Oyen W.J. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther 4 4 (2004) 607-613
73. Stippel D.L., Brochhagen H.G., Arenja M., Hunkemöller J., Hölscher A.H., and Beckurts K.T. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol 11 4 (2004) 420-425
74. de Baere T., Bessoud B., Dromain C., et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 178 1 (2002) 53-59
75. Goldberg S.N., Hahn P.F., Tanabe K.K., et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 9 1 Pt 1 (1998) 101-111
76. Yamasaki T., Kimura T., Kurokawa F., et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 40 2 (2005) 171-178
77. Hiraki T., and Kanazawa S. Hepatic outflow obstruction created by balloon occlusion of the hepatic vein: induced hepatic hemodynamic changes and the therapeutic applications of hepatic venous occlusion with a balloon catheter in interventional radiology. Acta Med Okayama 59 5 (2005) 171-178
78. Nikfarjam M., Muralidharan V., Malcontenti-Wilson C., McLaren W., and Christophi C. Impact of blood flow occlusion on liver necrosis following thermal ablation. ANZ J Surg 76 1ndash2 (2006) 84-91
79. Shen P., Fleming S., Westcott C., and Challa V. Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: effect of the Pringle maneuver. J Surg Oncol 83 1 (2003) 36-41
80. Kuvshinoff B.W., and Ota D.M. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 132 4 (2002) 605-611 [discussion 611-612]
81. Solbiati L., Ierace T., Tonolini M., Osti V., and Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 13 2 (2001) 149-158
82. Marchal F., Elias D., Rauch P., et al. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver: study on the pig. Ann Surg 243 1 (2006) 82-88
83. Hong K., Khwaja A., Liapi E., Torbenson M.S., Georgiades C.S., and Geschwind J.F. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12 8 (2006) 2563-2567
84. Lewis A.L., Taylor R.R., Hall B., Gonzalez M.V., Willis S.L., and Stratford P.W. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17 8 (2006) 1335-1343
85. Aliberti C., Tilli M., Benea G., and Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 26 5B (2006) 3793-3795
86. McKay A., Dixon E., and Taylor M. Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg 93 10 (2006) 1192-1201
87. Gillams A.R., and Lees W.R. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 30 4 (2005) 419-426
88. Oshowo A., Gillams A., Harrison E., Lees W.R., and Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90 10 (2003) 1240-1243
89. Schindera S.T., Nelson R.C., DeLong D.M., and Clary B. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. J Vasc Interv Radiol 17 10 (2006) 1631-1637
90. Elias D., De Baere T., Smayra T., Ouellet J.F., Roche A., and Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89 6 (2002) 752-756
91. Elias D., Baton O., Sideris L., et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 90 1 (2005) 36-42
92. Elias D., Manganas D., Benizri E., et al. The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer. J Surg Oncol 93 1 (2006) 8-12
93. Giantonio B.J., Levy D.E., O'dwyer P.J., Meropol N.J., Catalano P.J., and Benson III A.B. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Co-operative Oncology Group study E2200. Ann Oncol 17 9 (2006) 1399-1403
94. Goyle S., and Maraveyas A. Chemotherapy for colorectal cancer. Dig Surg 22 6 (2005) 401-414
95. Hurwitz H.I., Fehrenbacher L., Hainsworth J.D., et al. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23 15 (2005) 3502-3508
96. Nikfarjam M., Muralidharan V., and Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 139 1 (2006) 73-81
97. Christophi C., Nikfarjam M., Malcontenti-Wilson C., and Muralidharan V. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy. World J Surg 28 10 (2004) 987-994
98. Pacella C.M., Valle D., Bizzarri G., et al. Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: results of a phase II study. Acta Oncol 45 1 (2006) 77-83
99. Seifert J.K., and Junginger T. Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol 30 1 (2004) 34-40
100. Seifert J.K., and Junginger T. Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature. Technol Cancer Res Treat 3 2 (2004) 151-163
101. Seifert J.K., Springer A., Baier P., and Junginger T. Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study. Int J Colorectal Dis 20 6 (2005) 507-520
102. Shono Y., Tabuse K., Tsuji T., et al. Microwave coagulation therapy for unresectable colorectal metastatic liver tumor. Gan To Kagaku Ryoho 29 6 (2002) 856-859
103. Liang P., Dong B.W., Yu X.L., et al. Evaluation of long-term therapeutic effects of ultrasound-guided percutaneous microwave ablation of liver metastases. Zhonghua Yi Xue Za Zhi 86 12 (2006) 806-810
104. Tanaka K., Shimada H., Nagano Y., Endo I., Sekido H., and Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139 2 (2006) 263-273
105. Morita T., Shibata T., Okuyama M., et al. Microwave coagulation therapy for liver metastases from colorectal cancer. Gan To Kagaku Ryoho 31 5 (2004) 695-699
106. Zhang F.J., Wu P.H., Zhao M., Gu Y.K., Zhang L., and Tan Z.B. Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 27 4 (2005) 248-250
107. Xu Z.M., Wang J.H., Zhen Z.J., Chen H.W., and Cui W.Z. Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 26 11 (2006) 1626-1628
108. Kurokohchi K., Hosomi N., Yoshitake A., et al. Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation. Oncol Rep 16 5 (2006) 1067-1070
109. Gasparini D., Sponza M., Marzio A., Zanardi R., Bazzocchi M., and Cemal Y. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Radiol Med (Torino) 104 5-6 (2002) 412-420
110. Illing R.O., Kennedy J.E., Wu F., et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93 8 (2005) 890-895